Harvey J N, Jaffa A A, Loadholt C B, Mayfield R K
Department of Medicine, Medical University of South Carolina, Charleston.
Diabetes Res. 1988 Oct;9(2):67-72.
Following an intravenous injection of an isotopically-labelled clearance marker, glomerular filtration rate (GFR) or renal plasma flow (RPF) can be measured from the rate of plasma isotope disappearance, without collecting urine. The plasma disappearance curve can be closely approximated from a single, timed plasma measurement, if the volume of distribution (V) of the marker is known. Although V is generally predicted from body weight, effects of disease states on the relationship between V and body weight have not been studied. To apply this method of measuring GFR and RPF in streptozotocin-diabetic rats, we investigated the effects of diabetes and insulin treatment on V of 51Cr-EDTA and 125I-orthoiodohippuran (OIH). In untreated diabetic, insulin-treated diabetic and control rats, highly significant linear relationships were found between body weight and V of either isotope (r = 0.68-0.97). However, the slopes and intercepts of these relationships showed that diabetes and insulin treatment significantly altered V of 51Cr-EDTA and 125I-OIH. The greatest change was observed in untreated diabetic rats, in which V of 125I-OIH was increased approximately 12% compared to V in weight-matched control rats. Insulin treatment partially reversed this effect, but V of 125I-OIH in insulin-treated diabetic rats remained increased compared to controls. Using the relationships we derived for V vs body weight, GFR and RPF were measured in the three groups of rats by the single-injection, single-plasma sample method. Severely hyperglycemic, untreated diabetic rats showed reduced RPF (p less than 0.005) but no significant reduction in GFR, compared to age-matched control rats.(ABSTRACT TRUNCATED AT 250 WORDS)
静脉注射同位素标记的清除标志物后,无需收集尿液,通过血浆同位素消失率即可测量肾小球滤过率(GFR)或肾血浆流量(RPF)。如果已知标志物的分布容积(V),则可通过单次定时血浆测量来精确拟合血浆消失曲线。尽管V通常根据体重来预测,但尚未研究疾病状态对V与体重之间关系的影响。为了在链脲佐菌素诱导的糖尿病大鼠中应用这种测量GFR和RPF的方法,我们研究了糖尿病和胰岛素治疗对51Cr-乙二胺四乙酸(EDTA)和125I-邻碘马尿酸(OIH)的V的影响。在未治疗的糖尿病大鼠、胰岛素治疗的糖尿病大鼠和对照大鼠中,发现两种同位素的体重与V之间均存在高度显著的线性关系(r = 0.68 - 0.97)。然而,这些关系的斜率和截距表明,糖尿病和胰岛素治疗显著改变了51Cr-EDTA和125I-OIH的V。在未治疗的糖尿病大鼠中观察到最大变化,其中125I-OIH的V比体重匹配的对照大鼠增加了约12%。胰岛素治疗部分逆转了这种效应,但胰岛素治疗的糖尿病大鼠中125I-OIH的V与对照相比仍有所增加。利用我们得出的V与体重的关系,通过单次注射、单份血浆样本法在三组大鼠中测量了GFR和RPF。与年龄匹配的对照大鼠相比,严重高血糖的未治疗糖尿病大鼠的RPF降低(p < 0.005),但GFR无显著降低。(摘要截短至250字)